Latest News about IMGN
Recent news which mentions IMGN
   Earnings Scheduled For May 6, 2022
   
  
  
  May 06, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   75 Biggest Movers From Yesterday
   
  
  
  March 22, 2022
  From Benzinga
 
   Why Coinbase and Immunogen Led the Nasdaq Lower Monday
   
  
  
  March 21, 2022
  From Motley Fool
 
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  March 21, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  March 21, 2022
  From Benzinga
 
   46 Stocks Moving In Monday's Mid-Day Session
   
  
  
  March 21, 2022
  From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  March 21, 2022
  From Benzinga
 
   Why Are ImmunoGen Shares Trading Lower Today
   
  
  
  March 21, 2022
  From Benzinga
 From InvestorPlace
 
   28 Stocks Moving in Monday's Pre-Market Session
   
  
  
  March 21, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
   
  
  
  February 25, 2022
  From Benzinga
 
   Earnings Scheduled For February 25, 2022
   
  
  
  February 25, 2022
  From Benzinga
 
   The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
   
  
  
  February 20, 2022
  From Benzinga
 
   Lilly Unites With ImmunoGen In ADC Deal Worth Up To $1.7B
   
  
  
  February 15, 2022
  From Benzinga
 
   Why Sutro Biopharma Stock Is Losing Ground Today
   
  
  
  January 06, 2022
  From Motley Fool
 
   Why Shares of ImmunoGen Jumped 20.3% in December
   
  
  
  January 03, 2022
  From Motley Fool
 
   3 Under-the-Radar Biotech Stocks to Buy in 2022
   
  
  
  December 11, 2021
  From Motley Fool
 
   The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
   
  
  
  December 06, 2021
  From Benzinga
 
   61 Biggest Movers From Yesterday
   
  
  
  December 02, 2021
  From Benzinga
 
   Why Adaptimmune Therapeutics Stock Is Crashing Today
   
  
  
  December 01, 2021
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.